One of the chapters in the book, The AI Revolution in Medicine: GPT-4 and Beyond, relates to the possible applications for AI within the field of scientific discovery and clinical trials. Some of the possibilities covered include that once live internet access is fully integrated with GPT-4, it should be able to identify live trials a patient may qualify for.

There are already AI systems available for performing chart reviews to assess a patient’s suitability for a trial, and these are only likely to improve and become more efficient.

Reviewing current trial data is another area that can be speeded up, as well as looking at the results of previous trials when preparing to design a new one.

And from the perspective of the patient experience, GPT-4 can translate the trial jargon so it’s easier to understand, as well as answer questions as they occur at any stage of participating.

You may also like

Biotech C-suites Should keep Patient Recruitment in Mind from the Outset
In biotech, a strong C-suite isn’t just about job titles - it’s about covering every part of the journey from discovery to delivery. Including being prepared to tackle one of the biggest ...
Key C-suite Roles for Biotech Success - The Chief Patient Recruitment Officer (CPRO)
While biotech companies have built C-suites with scientific, medical, financial, operational, and business expertise, a critical function has remained conspicuously absent - addressing one ...
Key C-suite Roles for Biotech Success - The Chief Business Officer (CBO)
The Chief Business Officer leads external strategy - licensing deals, identifying pharma partnerships, and developing long-term growth planning and market positioning strategies that ...